A nationwide Alzheimer's clinical trial, BenfoTeam, is being locally administered by MedVadis, a partner of Boston Advanced Medicine based in Waltham.
An ongoing clinical trial, BenfoTeam, is being administered in Greater Boston as well as dozens of communities across the country. Researchers hope a lab-made version of thiamine, or Vitamin B1, can help to slow cognitive decline in people with early Alzheimer'sResearchers say this treatment could be especially beneficial because the drug is converted by the body into Vitamin B1, or thiamine.
A new study is tying high doses of common ADHD treatments like Adderall to increased risk of manic or psychotic episodes. Over six million people 65 and over have the disease in the United States. In its advanced stages, Alzheimer's can cause complications that lead to death, including dehydration and infection.Patients in this study would have early forms of the disease, meaning their symptoms would mainly be limited to mild difficulties during everyday memory recalls and other tasks. Participants will either be given the benfotiamine or a placebo pill and will be followed for 18 months.
That's the case for Tim Muther of Holliston. Now in his late 70s, he is living with Alzheimer's and is participating in a clinical trial in hopes of helping to contribute to the search for a cure. "Forgetting things, you know, things that I either should have done or, you know, or things that I felt that I should know that answer," he said."They just weren't there."
"I'm hoping that by me participating and maybe I'll give some hope to others," he said."I can feel some benefits from what I've been doing... I am holding my own."
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'A nationwide Alzheimer's clinical trial, BenfoTeam, is being locally administered by MedVadis, a partner of Boston Advanced Medicine based in Waltham.
Read more »
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'A nationwide Alzheimer's clinical trial, BenfoTeam, is being locally administered by MedVadis, a partner of Boston Advanced Medicine based in Waltham.
Read more »
New AI model enhances clinical trial approval predictions by quantifying uncertaintyResearchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves the prediction accuracy of clinical trial approvals.
Read more »
Clinical trial supports adding ruxolitinib to tyrosine kinase inhibitors for chronic myeloid leukemiaResearchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor (TKI) treatment for patients with chronic-phase chronic myeloid leukemia (CP-CML) significantly increased the percentage of patients who had a molecular response deep enough to warrant discontinuing treatment.
Read more »
Clinical trial: Cholesterol drug ineffective for treatment of multiple sclerosisResults of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression.
Read more »
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypesClinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).
Read more »